Public Policy

Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.

The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

Patrick J. Kennedy, former U.S. Representative, and Nawal Roy, founder and CEO of Holmusk, discuss how the pair are using experience and data to create a policy guide for lawmakers.

Former U.S. Representative Patrick J. Kennedy and Nawal Roy, founder and CEO of Holmusk, relay how clinical data can help solidify mental health coverage.

The smartphone-sized device offers continuous monitoring of respiration rate while allowing patient mobility.

The agencies contacted 130 health systems and telehealth providers by mail to emphasize the potential HIPAA risks of using Meta/Facebook pixel and Google Analytics tracking tools that may be "impermissibly disclosing" protected health information.  

The Ohio-based company's XR90 offering allows physicians to view a patient's anatomical structures in 3D for preoperative and intraoperative use. 

The FDA-cleared and CE-marked image analysis software helps providers diagnose and monitor patients with neurological conditions.

BabySat, available via prescription, alerts parents when their baby's heart rate or blood oxygen saturation falls out of a prescribed range.

The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.